These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 32970810)
1. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia? Wang W; Thakral B Blood; 2020 Sep; 136(13):1565. PubMed ID: 32970810 [No Abstract] [Full Text] [Related]
2. Blastic plasmacytoid dendritic cell neoplasm or CD4+ CD56+ acute myeloid leukemia: A case report. Neji S; Lakhal FB; Salem SF; Ghali O; Neji HB; Achour M; El Borgi W; Gouider E Ann Biol Clin (Paris); 2024 Sep; 82(4):405-412. PubMed ID: 39210590 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm. Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374 [No Abstract] [Full Text] [Related]
4. Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports. Lee JM; Kim IS; Lee JN; Park SH; Kim HH; Chang CL; Lee EY; Kim HR; Oh SH; Song SA Ann Lab Med; 2016 Sep; 36(5):494-7. PubMed ID: 27374717 [No Abstract] [Full Text] [Related]
5. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm. Zhang X; Wu Y; Li C; Shen K; Li R Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129 [TBL] [Abstract][Full Text] [Related]
6. [Plasmacytoid dendritic cell neoplasm in a 71 year-old male]. Centurión MÉ; Navarro JT; Millá F; Feliu E Med Clin (Barc); 2011 Jul; 137(4):189-90. PubMed ID: 21310442 [No Abstract] [Full Text] [Related]
7. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313 [TBL] [Abstract][Full Text] [Related]
8. Clinical and biologic features of CD4(+)CD56(+) malignancies. Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm. Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050 [TBL] [Abstract][Full Text] [Related]
10. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152 [TBL] [Abstract][Full Text] [Related]
12. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha). Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395 [TBL] [Abstract][Full Text] [Related]
13. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study]. Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672 [TBL] [Abstract][Full Text] [Related]
14. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases]. Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384 [TBL] [Abstract][Full Text] [Related]
15. A rare case of acute leukemic presentation of blastic plasmacytoid dendritic cell neoplasm without cutaneous lesions. Yu S; Kwon MJ; Kim K; Koo DH; Woo HY; Park H Ann Lab Med; 2014 Mar; 34(2):148-51. PubMed ID: 24624352 [No Abstract] [Full Text] [Related]
16. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related]
17. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion. Awasthi NP; Qayoom S; Dabadghao S J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977 [TBL] [Abstract][Full Text] [Related]
18. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. Cheng W; Yu TT; Tang AP; He Young K; Yu L Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354 [TBL] [Abstract][Full Text] [Related]
19. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset. Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340 [TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. Shi Y; Wang E Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]